Schizophrenia Archives - Page 3 of 4

Live Event – Proposed Role Of Modulating Norepinephrine In Psychiatry Illnesses

Live Event July 13 6:00 pm to 8:00 pm EDT

Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental… Read More

Virtual Event – Importance of Adherence to Outcomes in Schizophrenia & Bipolar Disorder

Regional/Local June 16 12:00 pm to 1:00 pm EDT

Speakers Dennis Sholler, PhD and Amica Simmons-Yon, PharmD, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Read More

Live Event – Proposed Role of Modulating Norepinephrine in Psychiatry Illnesses

Live Event May 18 6:00 pm to 8:00 pm EDT

Speaker Salvatore G. Savatta, MD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development… Read More

Virtual Event – Proposed Role Of Modulating Norepinephrine In Psychiatric Illnesses

National May 9 2:00 pm to 3:00 pm EDT

Speakers Dennis Sholler, PhD and Simon Kim, PharmD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. Read More

Virtual Event – Distinguishing Sedation VS Efficacy In Antipsychotic Treatment

National June 14 12:00 pm to 1:00 pm CDT

Speaker Stephen R Saklad, PharmD, BCPP is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Dennis Pabis, PharmD, BCPP is an employee of Otsuka Pharmaceutical Development & Commercialization,… Read More

Virtual Event – Considerations & Factors For Initiating & Switching Antipsychotic Medications In Schizophrenia

Regional/Local April 26 12:00 pm to 1:00 pm EDT

Speaker Salvatore G. Savatta, MD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speakers Becky Wong, PharmD, MBA and Brijesh Patel, PharmD are employees of Otsuka Pharmaceutical Development… Read More

Virtual Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Regional/Local April 12 2:00 pm to 3:00 pm EDT

Speaker Martin Guerrero, MD, JD is a paid consultant for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Jessie Chambers, PhD is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. Read More

Live Event – Addressing The Transition Of Care For Patients With Schizophrenia: A Case Study Approach

Live Event March 23 6:30 pm to 7:30 pm PDT

Speakers Hiten Patadia, PharmD and Sucharita Somkuwar, PhD, BPharm are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental… Read More

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event April 14 6:30 pm to 7:30 pm PDT

Speaker David Block, MD, MMM is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc.Speaker Sucharita Somkuwar, PhD, BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc.… Read More

Live Event – Importance Of Adherence To Outcomes In Schizophrenia & Bipolar Disorder

Live Event March 15 3:00 pm to 4:00 pm EDT

Speaker Sucharita Somkuwar, PhD BPharm is an employee of Otsuka Pharmaceutical Development & Commercialization, Inc. PSYCHU PROGRAM ATTENDANCE ELIGIBILITY REQUIREMENTS PsychU is supported by Otsuka Pharmaceutical Developmental & Commercialization Inc.,… Read More

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: